Lazard Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4
| Closed | -$1K | – | 2605 |
|
|
2024
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 2247 |
|
|
2024
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 2224 |
|
|
2024
Q2 | $1K | Sell |
4
-2
| -33% | -$707 | ﹤0.01% | 2195 |
|
|
2024
Q1 | $2K | Sell |
6
-6,117
| -100% | -$2.26M | ﹤0.01% | 1949 |
|
|
2023
Q4 | $2.15M | Sell |
6,123
-2,321
| -27% | -$821K | ﹤0.01% | 838 |
|
|
2023
Q3 | $3.17M | Sell |
8,444
-153
| -2% | -$59.2K | ﹤0.01% | 791 |
|
|
2023
Q2 | $3.29M | Buy |
8,597
+8,343
| +3,285% | +$2.98M | ﹤0.01% | 795 |
|
|
2023
Q1 | $87K | Buy |
254
+8
| +3% | +$2.34K | ﹤0.01% | 1588 |
|
|
2022
Q4 | $57K | Buy |
246
+87
| +55% | +$20.6K | ﹤0.01% | 1744 |
|
|
2022
Q3 | $38K | Sell |
159
-9,058
| -98% | -$2.76M | ﹤0.01% | 1909 |
|
|
2022
Q2 | $2.79M | Sell |
9,217
-21,092
| -70% | -$6.86M | ﹤0.01% | 841 |
|
|
2022
Q1 | $12.4M | Sell |
30,309
-2,832
| -9% | -$1.11M | 0.01% | 565 |
|
|
2021
Q4 | $15.5M | Sell |
33,141
-17,432
| -34% | -$7.5M | 0.02% | 535 |
|
|
2021
Q3 | $21.5M | Sell |
50,573
-70,872
| -58% | -$29.9M | 0.02% | 455 |
|
|
2021
Q2 | $43.6M | Sell |
121,445
-3,777
| -3% | -$1.25M | 0.05% | 311 |
|
|
2021
Q1 | $35.3M | Sell |
125,222
-4,981
| -4% | -$1.43M | 0.04% | 325 |
|
|
2020
Q4 | $36.9M | Buy |
130,203
+3,453
| +3% | +$969K | 0.05% | 321 |
|
|
2020
Q3 | $34.8M | Buy |
126,750
+13,095
| +12% | +$3.47M | 0.05% | 291 |
|
|
2020
Q2 | $25.8M | Buy |
113,655
+26,676
| +31% | +$5.24M | 0.04% | 326 |
|
|
2020
Q1 | $13.2M | Sell |
86,979
-2,185
| -2% | -$336K | 0.02% | 379 |
|
|
2019
Q4 | $13.4M | Buy |
+89,164
| New | +$13M | 0.02% | 408 |
|
Other funds holding WST
DCP
